These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11213883)
1. Macrophage activation in type 1 diabetic patients with catheter obstruction during peritoneal insulin delivery with an implantable pump. Kessler L; Tritschler S; Bohbot A; Sigrist S; Karsten V; Boivin S; Dufour P; Belcourt A; Pinget M Diabetes Care; 2001 Feb; 24(2):302-7. PubMed ID: 11213883 [TBL] [Abstract][Full Text] [Related]
2. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience. Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B; Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889 [TBL] [Abstract][Full Text] [Related]
3. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials. Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471 [TBL] [Abstract][Full Text] [Related]
4. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data. Kjærulff MLBG; Astrup BS J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551 [TBL] [Abstract][Full Text] [Related]
5. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps. Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863 [TBL] [Abstract][Full Text] [Related]
6. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group. Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967 [TBL] [Abstract][Full Text] [Related]
7. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs. Hanaire-Broutin H; Broussolle C; Jeandidier N; Renard E; Guerci B; Haardt MJ; Lassmann-Vague V Diabetes Care; 1995 Mar; 18(3):388-92. PubMed ID: 7555483 [TBL] [Abstract][Full Text] [Related]
15. Long-term implantation of a new implantable programmable insulin pump in two diabetic dogs. Scavini M; Day PW; Eaton RP Artif Organs; 1992 Oct; 16(5):518-22. PubMed ID: 10078304 [TBL] [Abstract][Full Text] [Related]
16. Implantable insulin pumps: diagnosis and management of decreased flow rates using radionuclide investigation. Boulahdour H; Behar A; Haardt MJ; Selam JL Int J Artif Organs; 1996 Dec; 19(12):723-9. PubMed ID: 9029249 [TBL] [Abstract][Full Text] [Related]
20. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps. Catargi B; Breilh D; Gin H; Rigalleau V; Saux MC; Roger P; Tabarin A Diabetes Metab; 2001 Jun; 27(3):323-7. PubMed ID: 11431597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]